StockData
Surrozen, Inc./DE logo

Surrozen, Inc./DE (SRZN) stock

SRZNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$31.74+1.76 (+5.87%)

Close on Nov 18, 2026Market cap $373.06MP/E –Yield –

Surrozen market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Surrozen's market cap was $374.72M on Nov 11, 2026, against $142.11M a year earlier. Over the last 5 years it ranged from $11.68M to $378.24M, with a median of $70.95M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$374.72M+93.4%
2025Dec 31, 2025$193.70M+315.3%
2024Dec 31, 2024$46.64M+143.4%
2023Dec 29, 2023$19.16M-6.2%
2022Dec 30, 2022$20.44M-90.9%
2021Dec 31, 2021$225.57M–

More Surrozen figures

See a number that looks wrong?